跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANECREAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ANECREAM
Authorized
STANDARD
ANECREAM
Focus Health Group, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0e8cac33ce312a14
Company
Focus Health Group, Inc.
Type
Standard
Approval Details
Approval Id
0e8cac33ce312a14
Drug Approval Canada Name
ANECREAM
Product Name
ANECREAM
Status
Cancelled Pre Market
Status Date
2021-08-10
Din
02402491
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:08.00
Atc Original
D04AB01 LIDOCAINE
Atc Name
d 04 ab 01
Aig Number
0103565009
Company Name
Focus Health Group, Inc.
Company Address
5802 Kingston Pike, Knoxville, Tennessee, United States, 37919
Company Detail Path
/organization/focus-health-group-inc
Company Information
Pharmaceutical Company Name
Focus Health Group, Inc.
Country Name
United States
Province Name
Tennessee
City Name
knoxville,tennessee,country_us
Address
5802 Kingston Pike
Active Ingredients
LIDOCAINE
4 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0e8cac33ce312a14
Type
Standard
Back to Health Canada Approvals